Harrold, Leslie R.
Patel, Pankaj A.
Griffith, Jenny
Litman, Heather J.
Feng, Hua
Schlacher, Casey A.
Kremer, Joel M.
Funding for this research was provided by:
Corrona, LLC (-)
AbbVie (-)
Article History
Received: 13 May 2019
Revised: 16 July 2019
Accepted: 30 July 2019
First Online: 21 October 2019
Compliance with ethical standards
: All patients provided written informed consent and authorization before enrollment in the Corrona registry. Participating investigators were required to obtain full board approval for conducting noninterventional research involving human subjects with a limited dataset. Institutional review board (IRB) approvals for the registry and the current study were obtained from a central IRB (New England IRB (NEIRB; No. 120160610)) for private practice sites and from local IRBs for each participating academic site. For academic sites that did not receive a waiver to use the central IRB, documentation of approval from the respective local IRB was submitted to Corrona, LLC, prior to the initiation of any study procedures.
: LR Harrold is an employee and shareholder of Corrona, LLC. She has been a consultant to AbbVie, BMS, and Roche and had a research grant from Pfizer.HJ Litman and H Feng are employees of Corrona, LLC.PA Patel, J Griffith, and CA Schlacher are employees of AbbVie and own AbbVie stock.JM Kremer is an employee and shareholder of Corrona, LLC; a consultant for AbbVie, Amgen, BMS, Genentech, Lilly, Regeneron, Sanofi, and Pfizer and received research grants from: AbbVie, Genentech, Lilly, Novartis, and Pfizer.